|
Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Diabetes. 2004 Feb; 53(2):336-346.
Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB. |
|
Influence of gamma´ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate
Arterioscler Thromb Vasc Biol.. 2004 Feb; 24(2):382-6. Epub 2003 Dic 1
Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW |
|
Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells
Blood. 2004 Feb; 103(3):955-62. Epub 2003 Oct 2
Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR |
|
In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone
Blood. 2004 Feb; 103(3):897-902. Epub 2003 Sep 25
Taher Nassar, Sa´ed Akkawi, Ahuva Shina, Abdullah Haj-Yehia, Khalil Bdeir, Mark Tarshis, Samuel N. Heyman, and Abd Al-Roof Higazi |
|
The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
J Biol Chem. 2004 Ene; 279(5):3643-50. Epub 2003 Oct 31
Ibarra CA, Blouse GE, Christian TD, Shore JD |
|
Role of fibrinolysis in tissue-factor-induced disseminated intravascular
Haematologica. 2004 Ene; 89(6):757-8.
Asakura H, Sano Y, Yamazaki M, Morishita E, Miyamoto K, Nakao S. |
|
Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis.
Atherosclerosis. 2004 Ene; 174(2):225-3.
Jovin IS, Muller-Berghaus G |
|
Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.
FEBS Lett. 2004 Ene; 556(1-3):175-9.
Jensen JK, Durand MK, Skeldal S, Dupont DM, Bodker JS, Wind T, Andreasen PA. |
|
Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator.
Thromb Res. 2004 Ene; 113(6):Q345-51.
Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Alvarez-Sabin J |
|
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography.
Thromb Res. 2004 Ene; 113(5):341-3.
Siegling S, Thyzel E, Brinkmann T, Prohaska W, Gottig C, Kleesiek K, Glahn J. |
|
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1).
J Thromb Haemost. 2004 Ene; 2(1):16-22.
Lijnen HR, Van Hoef B, Umans K, Collen D. |
|
Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Thromb Res. 2004 Ene; 113(6):345-51.
Miyamoto S, Kawano H, Takazoe K, Soejima H, Sakamoto T, Hokamaki J, Yoshimura M, Nakamura H, Yodoi J, Ogawa H |
|
Factor XII-dependent increases in thrombin activity induce carboxypeptidase-mediated attenuation of pharmacological fibrinolysis.
J Thromb Haemost. 2004 Ene; 2(1):128-34.
Latacha MP, Schaiff WT, Eisenberg PR, Abendschein DR. |
|
New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Semin Hematol. 2004 Ene; 41(1 Suppl):13-9.
Bouma BN, Meijers JC. |
|
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Am Heart J.. 2004 Ene; 147(1):158-64.
Gyongyosi M, Glogar D, Weidinger F, Domanovits H, Laggner A, Wojta J, Zorn G, Iordanova N, Huber K. |
|
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.
J Clin Invest. 2004 Ene; 113(1):38-48.
Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, Hempstead B, Mark WH, Hajjar KA |
|
Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
Thromb Res. 2004 Ene; 114(1):57-65.
Cullen JP, Nicholl SM, Sayeed S, Sitzmann JV, Okada SS, Cahill PA, Redmond EM |
|
Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Circulation. 2003 Dic; 108(25):3079-83. Epub 2003 Dic 1
Pretorius M, Murphey LJ, McFarlane JA, Vaughan DE, Brown NJ. |
|
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.
J Biol Chem. 2003 Dic; 278(51):51059-67. Epub 2003 Oct 2
Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ, Pearl RG, Leung LL. |
|
Lung endothelium targeting for pulmonary embolism thrombolysis.
Circulation. 2003 Dic; 108(23):2892-8. Epub 2003 Nov 10
Ding BS, Zhou YJ, Chen XY, Zhang J, Zhang PX, Sun ZY, Tan XY, Liu JN. |
